(19)
(11) EP 1 181 287 A1

(12)

(43) Date of publication:
27.02.2002 Bulletin 2002/09

(21) Application number: 00935141.2

(22) Date of filing: 25.05.2000
(51) International Patent Classification (IPC)7C07D 401/14, C07D 403/12, C07D 401/12, C07D 401/06, C07D 207/48, A61K 31/454, A61P 25/24
(86) International application number:
PCT/EP0004/893
(87) International publication number:
WO 0073/299 (07.12.2000 Gazette 2000/49)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 01.06.1999 GB 9912701

(71) Applicant: SMITHKLINE BEECHAM PLC
Brentford, Middlesex TW8 9EP (GB)

(72) Inventor:
  • LOVELL, Peter John,SmithKline Beecham Pharm.
    Harlow,Essex CM19 5AW (GB)

(74) Representative: Filler, Wendy Anne, Dr. et al
GlaxoSmithKline Corporate Intellectual Property Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) SULFONAMIDE COMPOUNDS WITH PHARMACEUTICAL ACTIVITY